Key Insights

Highlights

Success Rate

57% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 87/100

Termination Rate

37.5%

3 terminated out of 8 trials

Success Rate

57.1%

-29.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed with results

Key Signals

2 with results57% success

Data Visualizations

Phase Distribution

6Total
Not Applicable (6)

Trial Status

Completed4
Terminated3
Recruiting1

Trial Success Rate

57.1%

Benchmark: 86.5%

Based on 4 completed trials

Clinical Trials (8)

Research Network

Activity Timeline